Company news

CareDx, Inc. news in 2022

CareDx, Inc.'s news releases, calls and decks from 2022, newest first.

View company

CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community

March 13, 2022

CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients

March 2, 2022

CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant Patients

March 1, 2022

CareDx Reports Fourth Quarter and Full Year 2021 Results

February 23, 2022

CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation

February 21, 2022

CareDx to Report Fourth Quarter and Full Year 2021 Financial Results

February 16, 2022

On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a Transplant

February 13, 2022

CareDx Taps into Its Patient Network to Deliver Insights on Transplant Needs

February 7, 2022

CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host “Heart Health” Webinar for Transplant Patients

February 6, 2022

CareDx To Participate In Upcoming Conferences

February 2, 2022

CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities

January 19, 2022

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance

January 11, 2022

CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies

January 10, 2022

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021

January 9, 2022

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection

January 6, 2022

CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch

January 5, 2022

CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy

January 4, 2022

CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients

January 3, 2022

← Newer news releases

Calls in 2022

Decks in 2022